As of 2025-05-22, the Fair Value of LogicBio Therapeutics Inc (LOGC) is -14.25 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.73 USD, the upside of LogicBio Therapeutics Inc is -284.39%.
With the market price of 7.73 USD and our fair value calculation, LogicBio Therapeutics Inc (LOGC) is not a good investment. Investing in LOGC stocks now will result in a potential loss of 284.39%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -745.00 | -361.00 | -384.00 | -317.00 | -75.00 | -376.40 |
| YoY growth | -477.52% | 51.54% | -6.37% | 17.45% | 76.34% | -67.71% |
| Market Cap (mil) | 203.38 |
| P/E | |
| Forward P/E |
| EPS | -2.85 |
| Avg earnings growth rate | -67.71% |
| TTM earnings | -75.00 |